CRISPR Therapeutics IPO Research Information

CRISPR Therapeutics IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on CRISPR Therapeutics, and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
CRISPR Therapeutics	CRSP - NASDAQ	$15.00-$17.00	$14.00	$15.00	4 million	10/19/2016
Underwriter(s): Citigroup, Piper Jaffray, Barclays
Co-Manager(s): Guggenheim Securities
Industry: Health Care
Filing(s): Filed 2016-09-09 Terms Added 2016-10-07

CRISPR Therapeutics Quote & Chart - Click for current quote - CRSP

About CRISPR Therapeutics (adapted from CRISPR Therapeutics prospectus):
They are a leading gene editing company focused on the development of CRISPR/Cas9-based therapeutics.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "CRSP" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.